Valeant Upgrade To $46B Allergan Bid Will Include Stock
Valeant Pharmaceuticals International Inc. on Tuesday confirmed it would beef up its $46 billion takeover offer for Allergan Inc. at a shareholder meeting later this month, but said the revised terms...To view the full article, register now.
Already a subscriber? Click here to view full article